DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/zw29tf/rhinoconjunctivit) has announced the addition of the “Rhino-Conjunctivitis-Pipeline Insights, 2016” report to their offering. Rhino-Conjunctivitis-Pipeline…
Uncategorized
VIDEO: Evidence mounts showing advantages of anti-VEGF therapy in proliferative diabetic retinopathy
WAIKOLOA, Hawaii — At Retina 2016, Michael S. Ip, MD, describes mounting evidence — anecdotal data, secondary outcomes data and study results from the DRCR.net Protocol S study — that anti-VEGF therapy is advantageous in patients with proliferative diabetic retinopathy.
Uncategorized
Response after three anti-VEGF injections predictive of long-term outcomes in DME, analysis shows
A post hoc analysis of Diabetic Retinopathy Clinical Research Network data showed that the long-term response to anti-VEGF treatment of diabetic macular edema can be assessed after three injections.The Early Anti-VEGF Response and Long-term Efficacy (E…
Inotek Pharmaceuticals to Present at Glaucoma 360 New Horizons Forum
LEXINGTON, Mass.–(BUSINESS WIRE)–Cadmus Rich, MD, Vice President, Medical Affairs and Clinical Development of Inotek, will present at Glaucoma 360: New Horizons Forum on Friday, January 29, 2016 at the Palace Hotel in San Francisco.
Uncorrected hyperopia may affect reading ability among preschoolers
A study funded by the National Eye Institute, part of the National Institutes of Health, has shown that uncorrected farsightedness (hyperopia) in preschool children is associated with significantly worse performance on a test of early literacy.
Edited stem cells offer hope of precision therapy for blindness
Findings raise the possibility of treating blinding eye diseases using a patient’s own corrected cells as replacement tissue.